Eric Venker - 20 Nov 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
President & Immunovant CEO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol
ROIV
Transactions as of
20 Nov 2025
Net transactions value
-$142,924
Form type
4
Filing time
24 Nov 2025, 21:00:13 UTC
Previous filing
07 Nov 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Venker Eric President & Immunovant CEO C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker 24 Nov 2025 0001801917

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Tax liability $142,924 -7,051 -0.47% $20.27 1,497,908 20 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.